Buffington Mohr McNeal »

Arrowhead Pharmaceuticals shares owned by Buffington Mohr McNeal

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Buffington Mohr McNeal from 13F filings

Historical chart of Buffington Mohr McNeal investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Buffington Mohr McNeal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Buffington Mohr McNeal

Quarter filed Position value Share count Share price at filing
2024-09-30 $581k 30k 19.37

More positions owned by Buffington Mohr McNeal

Schwab U.s. Large-cap Etf Etf (SCHX)
Microsoft Corp Stock (MSFT)
Costco Whsl Corp Stock (COST)
Ishares Core S&p 500 Etf Etf (IVV)
Technology Select Sector Spdr Fund Etf (XLK)
Pacer Us Small Cap Cash Cows 100 Etf Etf (CALF)
Jpmorgan International Research Enhanced Equity Etf Etf (JIRE)
Danaher Corporation Stock (DHR)
Thermo Fisher Scientific Stock (TMO)
Amphenol Corp New Cl A Stock (APH)
United Rentals Stock (URI)
Kkr & Co Stock (KKR)
Jpmorgan Chase & Co Stock (JPM)
Ishares Ibonds 2026 Corp Bond Etf (IBDR)
Ishares Ibonds 2031 Corp Bond Etf (IBDW)

View all positions for Buffington Mohr McNeal

Top funds holding Arrowhead Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Slate Path Capital
T. Rowe Price Investment Management
Geode Capital Management
Siren
Jpmorgan Chase & Co
Morgan Stanley
Northern Trust
Citadel Advisors
Goldman Sachs Group
Charles Schwab Investment Management
Rokos Capital Management

View all funds holding Arrowhead Pharmaceuticals